Something I've noticed about our nemesis of sorts, AXON: Around the middle of November when some of the regulars from here went over to the AXON board to raise certain issues, it looked like the only ones posting over there were "our" guys. I expected a flurry of AXON fans defending their "great" company, but, no. And it still is virtually desrted , only a handfull of posts since then, grand total of 56 posts (compared to AVXL's 49,366+). Checked SH, AXON doesn't even have a board there. Also very sparse on Yahoo.
Interestingly, one of the handful of relatively recent posts on Yahoo suggested a point, to the effect, that AXON is mostly owned by hedge funds. I take a peek at it once in a while, and keep wondering what is holding it up. There certainly does not appear to be any ongoing retail interest to speak of in AXON thus far.
In regard to the recent MF article, although it is accompanied by the apparently obligatory (albiet relatively mild) bash of AVXL, this the first AXON pump article I've come across in recent memory. I stopped following advice in Motley fool articles a few years ago after they recommended to buy Best Buy, right before it gapped down on a major sell-off. Got clipped on that one, been rather skeptical on Motley ever since. One needs to watch out for a lot of these buy recommendations that come out from seemingly established sources. It often means that somebody has a lot of shares to unload. And who to unload it on? Retail, of course.
Could be some of the hedge money in AXON is getting edgy and wants out, so, a hypothetical phase three or plan C might involve more of what we're seeing now with the Motley article. Who can say, could be good in a way if it is that simple. Obviously, with the recent overall market and sector drop, a lot of retails have exitted and are now sitting on some cash that may start to burn a hole in their pocket. Maybe the focus will shift to diverting buyers from some other biotechs to try to get them to buy AXON.
